A(selective) androgen receptor degraderordownregulator (SARD) is a type of drug which interacts with the androgen receptor (AR) such that it causes the AR to be degraded and thus downregulated.[1] They are under investigation for the treatment of prostate cancer and other androgen-dependent conditions.[1]
As of 2017, dimethylcurcumin (ASC-J9), a SARD, is under development for the treatment of acne vulgaris.[2]
| |||||||
---|---|---|---|---|---|---|---|
ARTooltip Androgen receptor |
| ||||||
GPRC6A |
| ||||||
|
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
This antineoplasticorimmunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |